A detailed history of Pnc Financial Services Group, Inc. transactions in Oncolytics Biotech Inc stock. As of the latest transaction made, Pnc Financial Services Group, Inc. holds 15,055 shares of ONCY stock, worth $11,742. This represents 0.0% of its overall portfolio holdings.

Number of Shares
15,055
Holding current value
$11,742
% of portfolio
0.0%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Feb 07, 2025

BUY
$0.74 - $1.4 $11,140 - $21,077
15,055 New
15,055 $14,000
Q3 2023

Nov 13, 2023

BUY
$1.98 - $3.24 $2,368 - $3,875
1,196 New
1,196 $2,000

Others Institutions Holding ONCY

About ONCOLYTICS BIOTECH INC


  • Ticker ONCY
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 57,867,400
  • Market Cap $45.1M
  • Description
  • Oncolytics Biotech Inc., a development-stage biopharmaceutical company, focuses on the discovery and development of pharmaceutical products for the treatment of cancer. Its lead product is pelareorep, an intravenously delivered immunotherapeutic agent for the treatment of solid tumors and hematological malignancies. Oncolytics Biotech Inc. has a...
More about ONCY
Track This Portfolio

Track Pnc Financial Services Group, Inc. Portfolio

Follow Pnc Financial Services Group, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Pnc Financial Services Group, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Pnc Financial Services Group, Inc. with notifications on news.